Tempus extends data licensing partnership with Recursion through November 2029

• Tempus extended its multi-year data license partnership with Recursion through November 2029.
• Deal resets original master agreement fees to committed payments totaling $42 million over three years.
• Prior structure included discretionary license fees potentially totaling $84 million over the next two years.
• Separate agreement grants a non-exclusive, worldwide license to Recursion’s RNA foundation model, TxFM.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Tempus AI Inc. published the original content used to generate this news brief via Business Wire (Ref. ID: 202609210914BIZWIRE_USPR_____20260920_BW789157) on September 21, 2026, and is solely responsible for the information contained therein.